Abstract
Background: Major challenges in the application of intensity-modulated proton therapy (IMPT) for lung cancer patients include the uncertainties associated with breathing motion, its mitigation and its consideration in IMPT optimization. The primary objective of this research was to evaluate the potential of four-dimensional robust optimization (4DRO) methodology to make IMPT dose distributions resilient to respiratory motion as well as to setup and range uncertainties; Methods: The effect of respiratory motion, characterized by different phases of 4D computed tomography (4DCT), was incorporated into an in-house 4DRO system. Dose distributions from multiple setup and range uncertainty scenarios were calculated for each of the ten phases of CT datasets. The 4DRO algorithm optimizes dose distributions to achieve target dose coverage and normal tissue sparing for multiple setup and range uncertainty scenarios as well as for all ten respiratory phases simultaneously. IMPT dose distributions of ten lung cancer patients with different tumor sizes and motion magnitudes were optimized to illustrate our approach and its potential; Results: Compared with treatment plans generated using the conventional planning target volume (PTV)-based optimization and 3D robust optimization (3DRO), plans generated by 4DRO were found to have superior clinical target volume coverage and dose robustness in the face of setup and range uncertainties as well as for respiratory motion. In most of the cases we studied, 4DRO also resulted in more homogeneous target dose distributions. Interestingly, such improvements were found even for cases in which moving diaphragms intruded into the proton beam paths; Conclusion: The incorporation of respiratory motion, along with setup and range uncertainties, into robust optimization, has the potential to improve the resilience of target and normal tissue dose distributions in IMPT plans in the face of the uncertainties considered. Moreover, it improves the optimality of plans compared to PTV-based optimization as well as 3DRO.
Highlights
Proton therapy, especially intensity-modulated proton therapy (IMPT) [1,2], has the potential to deliver higher doses to the target while keeping the doses to organs at risk (OARs) below tolerance levels [3]
DVHs were derived from the 90 dose distributions for patient’s plans optimized with the 4DRO, 3D robust optimization (3DRO) and planning target volume (PTV)-based optimization approaches
The band widths of clinical target volume (CTV) DVHs at critical dose and volume points quantitatively indicate the robustness of dose distributions—the narrower the band the more robust is the dose distribution. 4DRO is able to provide both superior robustness and superior CTV coverage in the face of respiratory motion compared to 3DRO
Summary
Especially intensity-modulated proton therapy (IMPT) [1,2], has the potential to deliver higher doses to the target while keeping the doses to organs at risk (OARs) below tolerance levels [3]. In most of the cases we studied, 4DRO resulted in more homogeneous target dose distributions Such improvements were found even for cases in which moving diaphragms intruded into the proton beam paths; Conclusion: The incorporation of respiratory motion, along with setup and range uncertainties, into robust optimization, has the potential to improve the resilience of target and normal tissue dose distributions in IMPT plans in the face of the uncertainties considered. It improves the optimality of plans compared to PTV-based optimization as well as 3DRO
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.